company background image
DGX logo

Quest Diagnostics NYSE:DGX Stok Raporu

Son Fiyat

US$154.33

Piyasa Değeri

US$17.3b

7D

-1.0%

1Y

15.3%

Güncellenmiş

04 Nov, 2024

Veri

Şirket Finansalları +

Quest Diagnostics Incorporated

NYSE:DGX Stok Raporu

Piyasa değeri: US$17.3b

DGX Stoklara Genel Bakış

Quest Diagnostics Incorporated, Amerika Birleşik Devletleri'nde ve uluslararası alanda tanısal testler ve hizmetler sunmaktadır.

Şirket hakkında

Ödüller

Adil değer tahminimizden 62.8% daha düşük bir oranda işlem görüyor
Kazançların yılda 11.71% oranında artması öngörülüyor
1.94% oranında güvenilir bir temettü öder
Rakiplerine ve sektöre kıyasla iyi değerde işlem görüyor

Risk Analizi

Yüksek borç seviyesine sahip

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

A Diagnostic Revolution And Health Strategy Propel Growth Towards Higher Margins

Key Takeaways Expansion through strategic acquisitions and partnerships is s The analysts have a consensus price target of $167.1 for Quest Diagnostics based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $185.0, and the most bearish reporting a price target of just $145.0. In order for you to agree with the analyst's consensus, you'd need to believe that by 2027, revenues will be $11.0 billion, earnings will come to $1.3 billion, and it would be trading on a PE ratio of 18.2x, assuming you use a discount rate of 5.9%.
View narrative
US$167.11
FV
7.6% undervalued intrinsic discount
4.84%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative

Quest Diagnostics Incorporated Rakipler

Labcorp Holdings

NYSE:LH

US$19.0b

DaVita

NYSE:DVA

US$11.6b

Chemed

NYSE:CHE

US$7.9b

CorVel

NasdaqGS:CRVL

US$5.2b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Quest Diagnostics
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$154.33
52 Haftanın En Yüksek SeviyesiUS$160.95
52 Haftanın En Düşük SeviyesiUS$123.04
Beta0.89
11 Aylık Değişim2.35%
3 Aylık Değişim5.07%
1 Yıllık Değişim15.27%
33 Yıllık Değişim8.52%
5 Yıllık Değişim53.07%
Halka arzdan bu yana değişim4,309.43%

Son Haberler & Güncellemeler

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Recent updates

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Feb 06
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 11
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Dec 24
Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Dec 06
Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Nov 18
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Quest Diagnostics: Moving Past Covid

Oct 25

Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

Sep 25
Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Sep 04
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Aug 13
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jul 11
Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Jun 09
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Quest Diagnostics: Healthier Diagnosis

May 30

Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

May 24
Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

May 09
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

Mar 22
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Feb 19
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Why Quest Diagnostics Isn't A 'Buy', My Oh My

Feb 14

Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Feb 05
Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Hissedar Getirileri

DGXUS HealthcareUS Pazar
7D-1.0%0.1%-1.6%
1Y15.3%1.5%30.8%

Getiri vs. Endüstri: DGX geçen yıl % 1.5 oranında getiri sağlayan US Healthcare sektörünü aştı.

Getiri vs Piyasa: DGX geçen yıl % 30.8 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is DGX's price volatile compared to industry and market?
DGX volatility
DGX Average Weekly Movement2.8%
Healthcare Industry Average Movement6.7%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

İstikrarlı Hisse Senedi Fiyatı: DGX son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: DGX 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
196744,000Jim Daviswww.questdiagnostics.com

Quest Diagnostics Incorporated, Amerika Birleşik Devletleri'nde ve uluslararası alanda tanı testleri ve hizmetleri sunmaktadır. Şirket rutin, rutin olmayan ve ileri klinik testler, anatomik patoloji testleri ve diğer tanısal bilgi hizmetleri gibi tanısal bilgi hizmetleri geliştirir ve sunar. Başta Quest Diagnostics markası olmak üzere AmeriPath, Dermpath Diagnostics, ExamOne ve Quanum markaları altında doktorlara, hastanelere, hastalara ve tüketicilere, sağlık planlarına, devlet kurumlarına, işverenlere, perakendecilere, ilaç şirketlerine ve sigortacılara ve sorumlu bakım kuruluşlarına laboratuvarlar, hasta hizmet merkezleri, doktor ofislerindeki flebotomistler, çağrı merkezleri ve mobil flebotomistler, hemşireler ve diğer sağlık ve zindelik profesyonellerinden oluşan bir ağ aracılığıyla tanısal bilgi hizmetleri sunmaktadır.

Quest Diagnostics Incorporated Temel Bilgiler Özeti

Quest Diagnostics'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
DGX temel i̇stati̇sti̇kler
Piyasa değeriUS$17.33b
Kazançlar(TTM)US$838.00m
Gelir(TTM)US$9.54b

20.6x

F/K Oranı

1.8x

P/S Oranı

DGX aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
DGX gelir tablosu (TTM)
GelirUS$9.54b
Gelir MaliyetiUS$6.39b
Brüt KârUS$3.15b
Diğer GiderlerUS$2.31b
KazançlarUS$838.00m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)7.51
Brüt Marj32.97%
Net Kâr Marjı8.79%
Borç/Özkaynak Oranı90.3%

DGX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

1.9%

Mevcut Temettü Verimi

39%

Ödeme Oranı